Corporate Board Profile
Filing Date | Source Excerpt |
---|---|
2024-03-13 | In this role he leads the advancement and execution of Merck’s strategy, with additional responsibility for business development and information technology. |
2025-03-12 | Chief Operating Officer, Eikon Therapeutics, Inc., a pioneering biotechnology company. |
Data sourced from SEC filings. Last updated: 2025-04-15